Tejinder Singh, MD
Transplant Surgery · Albany, NYNPI 1588650725
Payments from drug & device makers
Across 690 payments — averaging $1004.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$430K
- Johnson & Johnson$122K
- Davol Inc.$62K
- Covidien LP$51K
- Medical Device Business Services, Inc.$11K
- Conmed Corporation$7K
- plus $10K from 8 others
What the payments were for
- Consulting fees$65,62913%
- Speaking & faculty fees$29,4856%
- Travel & lodging$63,35012%
- Food & beverage$21,6554%
- Education$332,61565%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 571 | $430,284 |
| Johnson & Johnson(2 entities) | 61 | $121,771 |
| Davol Inc. | 7 | $62,459 |
| Covidien LP | 18 | $50,632 |
| Medical Device Business Services, Inc. | 1 | $11,211 |
| Conmed Corporation | 9 | $6,772 |
| W. L. Gore & Associates, Inc. | 12 | $5,001 |
| BD | 1 | $3,750 |
| Ethicon Endo-surgery Inc. | 1 | $850 |
| Medtronic | 1 | $134 |
| Novo Nordisk | 5 | $102 |
| Pacira Pharmaceuticals Incorporated | 1 | $76 |
| Ambu Inc. | 1 | $13 |
| Apollo Endosurgery US Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$423,211
- EVICEL Fibrin Sealant (Human)$23,079
- ECHELON FLEX Stapler$13,484
- ENSEAL Product Family$13,484
- HARMONIC Product Family$13,484
- Echelon Flex$9,595
- Enseal$9,595
- Harmonic$9,595
- AIRSEAL$6,530
- BIO-A Tissue Reinforcement$4,290
- DA VINCI SP$2,000
- SYNECOR Biomaterial$462
- Phasix Mesh$237
- Signia$134
- GORE ENFORM Preperitoneal Biomaterial$123
How this compares
$693,060 in reported general payments places this provider in the 95th percentile of 72 transplant surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 12 | $614 |
| Omeprazole | 54 | $498 |
| Terazosin Hcl | 12 | $92 |
| Finasteride | 11 | $56 |
| Losartan Potassium | 14 | $43 |
| Oxycodone Hcl | 15 | $41 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Albany
- Adam GriesemerNew York$1.3M
- Lloyd RatnerNew York$645K
- Roberto Hernandez AlejandroRochester$621K
- Kishore IyerNew York$296K
- Lewis TepermanNew York$225K
- Myron SchwartzNew York$199K
- Tomoaki KatoNew York$146K
- Tarunjeet KlairNew York$117K
- Vaughn WhittakerSyracuse$96K
- Jason HawksworthNew York$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.